Clever Leaves IPO Presentation

Financial Projections - Revised 2023 Projections Financial Forecast ($USD in mm) Revenue Adj. EBITDA $17.8 Flower Herbal Brands Extracts 50.9% Adj. Gross Margin 2022 $1.5mm capex (1) Flower category includes Branded Cannabinoid Products. $(23.1) 19% Revenue Breakdown by Product¹ 67% 2022 $17-$18 14% 55% -57% Adj. Gross Margin 2023 $0.2 $0.3mm capex $(11.0) - $(10.0) 29% 55% CLEVER LEAVES 2023 16% 13

View entire presentation